PATH | VRL
Menu

Find resources

Total results with these characteristics: 203

Disease: Meningococcus

Page 1 of 11
16th International Pathogenic Neisseria Conference: Recent Progress Toward Effective Meningococcal Disease Vaccines

This report, published in Human Vaccines, describes developments in meningococcal disease vaccines presented at the 16th International Pathogenic Neisseria Conference in Rotterdam in September 2008. It includes progress on an …

Author: Gorringe AR, van Alphen L

Publication date: 2009

Adult Vaccination Resources Library

This online library gathers resources specifically related to adult immunization, providing healthcare providers and the general public with access to relevant resources that can be used in a clinic setting or for individual education. It includes …

Author: Immunization Action Coalition

Advancing Vaccines and Immunization Issues, Insights, and Innovations

This supplement of Vaccine contains 16 articles that cover a broad spectrum of important issues in vaccine science, including vaccine safety, efficacy, and implementation. The overarching theme revolves around identifying barriers to vaccination and …

Author: Artenstein AW, Halsey NA, Nowak GJ, eds.

Publication date: 2015

Adverse Effects of Vaccines: Evidence and Causality

Though generally very rare or minor, there are side effects, or “adverse effects,” associated with some vaccines. This report provides an analysis of more than 1,000 research articles that were reviewed to assess the risk of specific adverse …

Author: Institute of Medicine

Publication date: 2011

Adverse Events Following Immunization During Mass Vaccination Campaigns at First Introduction of a Meningococcal A Conjugate Vaccine in Burkina Faso, 2010

MenAfriVac™ is a new meningococcal A conjugate vaccine developed to prevent meningitis outbreaks in Africa. It was first introduced during the last quarter of 2010 in three West African countries. The authors of this article, published in …

Author: Ouandaogo CR, Yaméogo TM, Diomandé FVK, et al.

Publication date: 2012

African Meningitis Belt

This map of the African continent displays the location of the Meningitis Belt, an area in Africa where a large number of meningitis epidemics occur.

Author: United Nations Country Team in Ethiopia

Publication date: 2001

Baseline Meningococcal Carriage in Burkina Faso Before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

The vaccine MenAfriVac™ has the potential to confer herd immunity by reducing carriage prevalence of epidemic strains. To better understand this phenomenon, the authors of this article, published in Clinical and Vaccine Immunology, initiated a …

Author: Kristiansen PA, Diomandé F, Wei SC, et al.

Publication date: 2011

Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid-CbpA Peptide Recombinant Fusion Protein

Pneumococcus, meningococcus and Haemophilus influenzae cause a similar spectrum of infections in the ear, lung, blood, and brain. They share cross-reactive antigens that bind to the laminin receptor of the blood-brain barrier as a molecular basis …

Author: Mann B, Thornton J, Heath R, et al.

Publication date: 2013

Can Successful Vaccines Teach Us How to Induce Efficient Protective Immune Responses?

This article, published in Nature Medicine, reviews current successful vaccines and identifies their mechanisms of protection in the hopes of tackling the challenges posed by those infectious targets that have thus far escaped successful …

Author: Lambert PH, Liu M, Siegrist CA

Publication date: 2005

Can We Defeat Meningococcal Disease in Low and Middle Income Countries?

This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological …

Author: Greenwood B, Chiarot E, MacLennan CA, O'Ryan M

Publication date: 2012

Can We, Should We, Eradicate the Meningococcus?

The authors of this article, published in Vaccine, discuss how the introduction of vaccines against Neisseria meningitidis raises the question of whether disease caused by this obligate human bacterium can be controlled, eliminated, or even …

Author: Maiden MC, Frosch M

Publication date: 2012

Center for Vaccine Innovation and Access

This web page provides information about the work of PATH’s Center for Vaccine Innovation and Access, which brings together expertise across every stage of vaccine research, development, and introduction to make lifesaving vaccines globally …

Author: PATH

Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998-2007: Implications for Prevention of Meningococcal Disease

This article, published in Clinical Infectious Diseases, describes the epidemiologic landscape of meningococcal disease in the United States from 1998 to 2007, including an analysis of the disease before and during the implementation of adolescent …

Author: Cohn AC, MacNeil JR, Harrison LH, et al.

Publication date: 2010

The Changing Epidemiology of Meningococcal Disease in North America 1945–2010

The epidemiology of Invasive Meningococcal Disease (IMD) is distinct in the United States and Canada compared with other countries. This review, published in Human Vaccines & Immunotherapeutics, describes the incidence, mortality, and …

Author: Baccarini C, Ternouth A, Wieffer H, Vyse A

Publication date: 2013

Climate Drives the Meningitis Epidemics Onset in West Africa

This study, published in PLoS Medicine, provides a clear, quantitative demonstration of the connections that exist between major meningococcal meningitis (MCM) epidemics and regional climate variability in Africa. This statistically robust …

Author: Sultan B, Labadi K, Guégan JF, Janicot S

Publication date: 2005

Clinical Presentation of Meningococcal Disease in Childhood

This article, published in the Journal of Preventative Medicine and Hygiene, provides an overview of the disease burden of meningococcal disease and the various vaccines available for meningococcal disease serogroups. Although relatively rare, …

Author: Sabatini C, Bosis S, Semino M, Senatore L, Principi N, Esposito S

Publication date: 2012

Clonal Properties of Meningococci From Epidemic Meningitis

This article, published in Transactions of the Royal Society of Tropical Medicine and Hygiene, reviews the classification of epidemic strains of Neisseria meningitidis and the expression by meningococci of both constant and highly variable …

Author: Achtman M

Publication date: 1991

Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight-Year Longitudinal Study in Northern Ghana

This study, published in PLoS Medicine, aimed to determine how levels of colonization with different bacterial meingococcal serogroups change over time, and how the patterns of disease relate to such changes in the Kassena-Nankana District of …

Author: Leimkugel J, Hodgson A, Forgor AA, et al.

Publication date: 2007

Clones of Neisseria meningitidis Strains in Mali

This article, published in Médecine et Maladies Infectieuses, provides an overview of a cross-sectional, descriptive study to identify strains of Neisseria meningitidis isolated from 2005 to 2007 in Mali. Neisseria meningitidis appeared in 144 of …

Author: Guindo I, Coulibaly A, Dao S, et al.

Publication date: 2010

Conducting Vaccine Clinical Trials in Sub-Saharan Africa: Operational Challenges and Lessons Learned From the Meningitis Vaccine Project

The Meningitis Vaccine Project (MVP) was established with the goal of developing, testing, licensing, and introducing an affordable group A meningococcal conjugate vaccine for Africa. The authors of this article, published in Vaccine, describe the …

Author: Marchetti E, Mazarin-Diop V, Chaumont J, et al.

Publication date: 2012

Page 1 of 11